Table: AFC-HD Ams Life Science -2019/20 group results
09/10/2020 07:10
Oct 9 (Reuters)-
AFC-HD Ams Life Science Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Aug 31, 2020 Aug 31, 2019 Aug 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 15.82 16.25 16.00 8.00
(-2.7 pct) (+2.9 pct) (+1.1 pct) (+1.4 pct)
Operating 1.09 981 mln 1.10 570 mln
(+11.5 pct) (-4.1 pct) (+0.6 pct) (+0.8 pct)
Recurring 1.10 1.01 1.10 570 mln
(+8.4 pct) (+3.3 pct) (+0.0 pct) (+0.4 pct)
Net
Net 676 mln 783 mln 720 mln 370 mln
(-13.6 pct) (+6.3 pct) (+6.4 pct) (+4.9 pct)
EPS 48.12 yen 55.70 yen 51.19 yen 26.30 yen
Ann Div 20.00 yen 25.00 yen 20.00 yen
-Q2 Div 10.00 yen 10.00 yen 10.00 yen
-Q4 Div 10.00 yen 15.00 yen 10.00 yen
NOTE - AFC-HD Ams Life Science Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T